Emergent BioSolutions Launches Opioid Emergency Preparedness 'Lay, Spray, Stay' Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith
Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024
Express News | Emergent BioSolutions Inc: Product With Extended Shelf Life Has Officially Begun Shipping
Express News | Emergent BioSolutions Announces Shelf-Life Extension for Narcan® Nasal Spray in Canada
Catalyst Watch: Earnings Deluge, Farnborough Airshow, Paris Olympics, and Trump Talks Crypto
How To Earn $500 A Month From American Express Stock Ahead Of Q2 Earnings
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
Emergent Biosolutions Grants Equity Award to Key Executive
Johnson & Johnson Faces MedTech Challenges But Is 'On Track' to Meet 2024 Guidance, Goldman Says
Emergent BioSolutions Secures $250M in Government Contract, Announces Strategic Moves Including Sale Of Baltimore Site to Boost Cash Generation and Slash Debt by $100M
Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan
Express News | On Monday, Johnson & Johnson Agreed To Pay $50M To Settle Claims Related To A Terminated Manufacturing Deal With Emergent BioSolutions Related To Johnson & Johnson's Covid-19 Vaccine - 8K
Emergent Biosolutions, Johnson & Johnson Settle Dispute Over COVID-19 Vaccine Manufacturing
Express News | Emergent BioSolutions- Deal to Resolve Claims From Manufacturing Services Deal for J&J's Investigational Sars-Cov-2 Vaccine, Ad26.cov2-S, Recombinant
Express News | Emergent BioSolutions Inc: Pursuant to Terms of Settlement Agreement, Janssen Will Pay Co $50 Mln on or Before July 31, 2024
Express News | Emergent BioSolutions - on July 3, Co, Unit, and Janssen Pharmaceuticals, Executed a Confidential Settlement Agreement and Release
Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday? (UPDATED)
Express News | Emergent Biosolutions Shares Are Trading Higher After the Company Announced It Has Received More Than $250 Million in Contract Modifications From the Administration for Strategic Preparedness and Response at the Department of Health and Human Services
Emergent Biosolutions Secures Major Vaccine Contracts With U.S.
Express News | Emergent BioSolutions Receives Over $250M In Contract Modifications From The HHS Administration For Strategic Preparedness And Response